Globenewswire·2025-09-24 05:00Company Overview - Sanofi is an R&D driven, AI-powered biopharma company focused on improving lives and delivering growth through innovative medicines and vaccines [2] - The company leverages its understanding of the immune system to create treatments that benefit millions globally, with a commitment to addressing urgent healthcare, environmental, and societal challenges [2] Financial Information - Sanofi's Q3 2025 Aide mémoire is now available on the company's website, which assists in financial modeling of quarterly results [1] - The document includes details on non-comparable items, foreign currency impact, and share count [1] - Sanofi's second quarter 2025 results are scheduled for publication on October 24, 2025 [1] Stock Information - Sanofi is listed on EURONEXT under the ticker SAN and on NASDAQ under the ticker SNY [3]